Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CD44 | P16070 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL559133 | 0.71 | — | — | |
| SCHEMBL9669 | 0.69 | ALDH1A1 (1.00) | ALDH1A1CYP3A4TSHRTDP1TP53 | |
| SCHEMBL1866504 | 0.69 | ALDH1A1 (1.00) | ALDH1A1CYP3A4TSHRTDP1TP53 | |
| SCHEMBL139002 | 0.69 | ALDH1A1 (0.65) | ALDH1A1CYP3A4TSHRTDP1TP53 | |
| SCHEMBL33589 | 0.69 | ALDH1A1 (0.65) | ALDH1A1CYP3A4TSHRTDP1TP53 | |
| SCHEMBL3210027 | 0.69 | ALDH1A1 (0.55) | ALDH1A1CYP3A4TSHRTDP1TP53 | |
| SCHEMBL24512194 | 0.69 | ALDH1A1 (0.60) | ALDH1A1CYP3A4TSHRMAPK1KDM4E | |
| Methane SCHEMBL2038793 | 0.67 | ALDH1A1 (0.61) | ALDH1A1CYP3A4TSHRTDP1TP53 | |
| Ammonia Solution, Strong SCHEMBL7696025 | 0.67 | ALDH1A1 (0.93) | ALDH1A1CYP3A4TSHRTDP1TP53 | |
| SCHEMBL4540248 | 0.67 | ALDH1A1 (0.93) | ALDH1A1CYP3A4TSHRTDP1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212125-A1 | COMPOUND AS POTASSIUM CHANNEL REGULATOR AND PREPARATION AND USE THEREOF | SHANGHAI ZHIMENG BIOPHARMA, INC. (CN) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212125-A1 | COMPOUND AS POTASSIUM CHANNEL REGULATOR AND PREPARATION AND USE THEREOF | KCNQ2, KCNQ1, KCNQ5 | ALDH1A1 3791/4885CYP3A4 716/4885TSHR 1648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.